참고문헌 (35)

1. Bonassar LJ, Vacanti CA : Tissue engineering: the first decade and beyond. J Cell Biochem. Suppl 1998;30-31:297-303 

2. Crane G, Ishuang S, Mikos A. : Bone Tissue Engineering: Nat Med. 1 : 1995;1322-1324 

3. Elahiff CM. Blackwell AS. HOllisJM. Feldman DS. : Analysis of a biodegradable composite for bone healing. J Biomed Mater Res. 1996;32(3):419-24 

4. Cho SB. MivaJi F. Kokubo T. Nakamura T. : Induction of bioactivity of a non-bioactive glassceramic by a chemical treatment. Biomaterials. 1997;18(22):1479-1485 

5. Radin S. Falaize S, Lee MH, Duchevne P. : In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials. Biomaterials. 2002;23(15):3113-22 

6. Dietmar Hutmacher, MS/Markus B. Hurzeler, Henning Schliephake : A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J of Oral&Maxillofacial Implants. 1996;11:667-678 

7. Gottlow J: Guided tissue regeneration using bioresorbable and non-resorbable devices ; Initial healing and long-term results. J Periodontol, 1993(supplement);64:1157-1167 

8. Greenstein G, Caton JG. : Biodegradable barriers and guided tissue regeneration. Periodontology 2000, 1993;1:36-45 

   상세보기

9. Chen J, Ma A, Lai Y, Chen Y, Cui M.: The mechanism of degradation for the absorbable biomaterials polyt(epsilon-caprolactone) in vitro and in vivo. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 1997;14(4):334-7 

10. Goodwin CJ. Braden M. Downes S. Marshell NJ. : Release of bioactive human growth hormone from a biodegradable material: poly (epsilon -caprolactone),J Biomed Mater Res. 1998;40(2):204-13 

11. Lang M. Bei J. Wang S. : Synthesis and characterization of polycaprolactone /poly( ethylene oxidel)/polylactide tri-componet copolymers.J Biomater Sci Polym Ed. 1999;10(4):501-12 

12. Ahola M. Rich J. Kortesuo P, Kiesvaara J. Seppala J. Yli-Urpo A.: In vitro evaluation of biodegradable varepsilon-caprolactone-co-D, Llactide/ silica xerogel composites containing toremifene citrate. Int J Pharm. 1999;30;181(2):181-91 

13. Iooss P. Le Ray AM. Grimandi G. Daculsi G. Merle C. :A new injectable bone substitute combining poly(epsilon-caprolactone) microparticles with biphasic calcium phosphate granules. Biomaterials. 2001;22(20):2785-94 

14. Kweon H. Yoo MK. Park IK, Kim TH. Lee HC. Lee HS. Oh JS. Aka. : A novel degradable polycaprolactone networks for tissue engineering. Biomaterials. 2003;24(5):801-8 

15. Ural E. Kesenci K. Fambri L. Migliaresi C. Piskin E. : Poly (D,L- lactide /epsilon -caprolactone) /hydroxyapatite composites. Biomaterials. 2000;21(21):2147-54 

16. Lin WJ. Flanagan DR, Linhardt RJ. : Accelerated degradation of poly (epsilon -eaprolactone) by organic amines.Pharm Res. 1994;11(7):1030-4 

17. Rhee SH. Choi JY. Kim HM. : Preparation of a bioactive and degradable poly (epsilon - caprolactone)/silica hybrid through a sol-gel method. Biomaterials. 2002;Dec;23(24):4915-21 

18. Rhee SH : Effect of molecular weight of poly(varepsilon -caprolactone) on interpenetrating network structure, apatite-forming ability, and degradability of poly( varepsilon -caprolac-tone)/silica nano-hybrid materials. Biomaterials. 2003;24(10):1721-7 

    상세보기

19. Rich J. Jaakkola T. Tirri T. Narhi T. Yli-Urpo A, Seppala J. : In vitro evaluation of poly(epsiloncaprolactone- co-DL-lactide)/ bioactive glass composites. Biomaterials, 2002;23(10):2143-50 

    상세보기

20. Li P. Ohtsuki C. Kokubo T, Nakanishi K, Saga N. Nakamura T. Yan : Effects of ions in aqueous media on hydroxyapatite induction by silica gel and its relevance to bioactivity of bioactive glasses and glass-ceramics. J Appl Biomater. 1993;4(3):221-9 

21. den Dunnen WF. Robinson PH. van Wessel R. Pennings AJ. van Lee : Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly (DL-lactide-epsiloncaprolactone), J Biomed Mater Res. 1997;5;36(3):337-46 

22. de Bruijn JD, van Bitterswijk CA, Davis JE. Initial bone matrix formation at the hydroxyapatite interface in nitro. J Biomed Mater Res 1995;29(1):89-99 

    상세보기

23. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 1981;157:259-278 

    상세보기

24. Jarcho M. Retrospective analysis of hydroxyapatite development for oral implant applications. Dent Clin North Am 1992;36(1):19-26 

    상세보기

25. Okumura M. Ohgushi H. Dohi Y, Katuda T, Tarnai S, Koerten HK, Tabata S. Osteoblastic phenotype expression on the surface of hydroxyapatite ceramics. J Biomed Mater Res 1997;37:122-129 

26. Damien CJ, Parson JR, Bone graft and bone bone graft substitutes: A review of current technology and applications. J Appl Boimater 2: 1991;187-201 

27. Habal ME, Reddi AH: Different Forms of Bone Grafts. In Habal MB, Reddi AH(eds). Bone Graft and Bone Substitues. Philadelphia,WB Saunders 1992;6-8 

28. Oonishi H: Orthopaedic applications of hydroxyapatite. Biomaterials 12: 1991;171-178 

29. Urist MR, O'Connor BT, Burwell RG: Bone Grafts Derivatives and Substitues. Oxford, Butterworth-Heinemann 1994 

30. Hollinger. J.O,, Battistone, G.C. : Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin, Orthop, 1986;207:290-305 

31. 의료용구의 생물학적 안전에 관한 공통기준규격, 식품의약품안전청 고시 2000;제 2000-13호 

32. Kazuo I and Toshie T : Enhancing effect of poly(L-lactide) on the differentiation of mouse osteoblast-like MC3T3-E1 cells Biomaterials. Aug;2003;24(19):3303-3309 

33. 우경미, Peter XM : 생체분해성 폴리머/칼슘포스 페이트결정 콤포지트 인공기질내로의 세포이주에 관한 연구 . 2000;대한구강해부학회지 27(1) :75-81 

34. Ignatius AA. Betz O. Augat P, Claes LE. : In vivo investigations on composites made of resorbable ceramics and poly(lactide) used as bone graft substitutes. J Biomed Mater Res. 2001;58(6):701-9 

35. Schantz JT, Hutmacher DW, Ng KW, Khor HL, Lim MT, Teoh SH.: Evaluation of a tissue-engineered membrane-cell construct for guided bone regeneration.Int J Oral Maxillofac Implants. 2002;17(2):161-74 

    상세보기

저자의 다른 논문 :

정근식 (1) 임성빈 (97) 정진형 (115) 홍기석 (32) 김종여 (18)